OCUL
OCULAR THERAPEUTIX INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
OCULAR THERAPEUTIX INC (OCUL) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$44.23M; the largest are Steven Cohen, Paul Tudor Jones, Renaissance Technologies. 2 tracked managers also disclosed PUT or CALL positions, reported separately below. This quarter: 4 trimmed, 1 closed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Cooling
Common-stock holders42 also report options
Congress trades0
Price$7.87vs quarter-end-19.86%
Sectors0
This quarter's moves
Top holderNew0
Added0
Trimmed / sold5
Steven CohenCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $3.44M— of portfolio350,4002026 Q2
Value $1.68M— of portfolio171,4002026 Q2
Value $1.52M— of portfolio154,7002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $3.44M | — | — |
| Paul Tudor JonesCALL | $1.68M | — | — |
| Ken GriffinPUT | $1.52M | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.